Opendata, web and dolomites

SWEET CROSSTALK SIGNED

Training interdisciplinary glycoscientists to get a molecular-level grip on glycocodes at the human mucosa–microbiota interface

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SWEET CROSSTALK project word cloud

Explore the words cloud of the SWEET CROSSTALK project. It provides you a very rough idea of what is the project "SWEET CROSSTALK" about.

equip    strategy    chemistry    biotech    innovative    complementary    generation    grip    drives    proteins    skills    glycan    credibility    transferable    disease    expert    interdisciplinary    fundamental    modulate    train    15    mucosa    biology    groups    synergy    crosstalk    intersectoral    health    job    chemical    competitive    outstanding    interactions    industry    partnership    microbiota    glycans    dominate    optimal    expertise    specialized    covers    diagnostics    interface    synthesis    glycocodes    understand    cell    combination    scientific    glycotherapeutics    smes    international    scientists    whereas    interacting    private    therapies    academic    biochemistry    reshaped    stage    public    platform    positioned    ranging    paradigm    smart    microbiology    sweet    multidisciplinary    time    obtaining    structural    arrived    healthcare    prophylactic    ensured    leaders    molecular    renowned    entire    correlates    training    microbiome    glycoscience    ideally    market    network    directs    quality    host    human    excellence   

Project "SWEET CROSSTALK" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITEIT UTRECHT 

Organization address
address: HEIDELBERGLAAN 8
city: UTRECHT
postcode: 3584 CS
website: www.uu.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 4˙117˙674 €
 EC max contribution 4˙117˙674 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2018
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITEIT UTRECHT NL (UTRECHT) coordinator 531˙239.00
2    QUADRAM INSTITUTE BIOSCIENCE UK (NORWICH) participant 606˙345.00
3    HELSINGIN YLIOPISTO FI (HELSINGIN YLIOPISTO) participant 561˙611.00
4    UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II IT (NAPOLI) participant 522˙999.00
5    ICENI DIAGNOSTICS LIMITED UK (NORWICH) participant 303˙172.00
6    GLYCOM AS DK (HORSHOLM) participant 297˙522.00
7    NUTRILEADS BV NL (WAGENINGEN) participant 265˙619.00
8    UNIVERSITEIT LEIDEN NL (LEIDEN) participant 265˙619.00
9    INBIOSE NV BE (GENT) participant 256˙320.00
10    UNIVERSITE CATHOLIQUE DE LOUVAIN BE (LOUVAIN LA NEUVE) participant 256˙320.00
11    UNIVERSITAT DE BARCELONA ES (BARCELONA) participant 250˙904.00
12    DANMARKS TEKNISKE UNIVERSITET DK (KGS LYNGBY) partner 0.00
13    UNIVERSITEIT GENT BE (GENT) partner 0.00
14    UNIVERSITY OF EAST ANGLIA UK (NORWICH) partner 0.00

Map

 Project objective

Sweet Crosstalk is a multidisciplinary European Training Network built to address the challenge of understanding, at a molecular level, how glycans are involved at the human mucosa–microbiota interface, and how this correlates with human well-being. Research into the human microbiome has reshaped the paradigm of our health and disease. In order to advance further, the time has arrived to understand it at a molecular level. Glycans dominate the microbiota-host interface and are thus ideally positioned to modulate these complex interactions. The research strategy of the Sweet Crosstalk programme focuses on optimal synergy between chemistry and biology. Smart chemistry drives the research to get a molecular-level grip on the role of these glycocodes and their interacting proteins, and advances in biology directs the research. The high quality and credibility of our consortium is ensured by a strong private-public partnership with complementary expertise ranging from chemical synthesis, biochemistry, structural biology to microbiology and cell biology. Our 7 academic groups are all renowned leaders in the glycoscience and microbiome fields, whereas the complementary 4 SMEs are specialized in glycan-based diagnostics and prophylactic therapies. This unique combination of scientific excellence and industry know-how covers the entire process from obtaining fundamental insight to the development of innovative early diagnostics and glycotherapeutics. Sweet Crosstalk also represents a unique research platform to train 15 outstanding Early Stage Researchers to be the new generation of innovative scientists with expert knowledge and skills in interdisciplinary glycoscience and human microbiome research. Our international, intersectoral and interdisciplinary training programme will equip them with the necessary scientific and transferable skills that will make them highly competitive for both top European research institutions and the healthcare/biotech job market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SWEET CROSSTALK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SWEET CROSSTALK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

ORBITAL (2019)

Ocular Research By Integrated Training And Learning

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

MLFPM2018 (2019)

Machine Learning Frontiers in Precision Medicine

Read More